Different Peptide Therapies: A Guide to Every Type

This article is published by Prometheuz Health, a men's health telehealth provider. Prometheuz offers FDA-approved TRT evaluation and prescriptions through a licensed, LegitScript-certified process. It reflects the commercial interests of the publisher. Content is for educational purposes only. It does not replace evaluation by your own licensed healthcare provider.

Different peptide therapies target specific pathways involved in blood sugar, appetite, hormone release, tissue signaling, immune function, skin health, and sexual function. Each peptide has its own uses, evidence, and safety considerations, and lumping them together under one label is where most of the confusion starts.

Peptide Therapy Isn't One Thing

"Peptide therapy" sounds like a single treatment, the way "physical therapy" describes one general approach. It isn't. It's a category name for dozens of different peptides that happen to share one structural trait and almost nothing else.

Some peptide medications are FDA-approved and backed by large trials. Others are compounded with far less oversight, and a few remain purely experimental. A peptide that helps with blood sugar tells you nothing about whether a different peptide helps with tissue repair. The product, route, dose, and intended use all matter more than the word "peptide" itself, and they're what a clinician reviews against your medical history before recommending anything.

What Are Peptides?

Peptides are short chains of amino acids that perform specific functions in the body, from signaling to structural support. Amino acids are the building blocks of proteins, and when a handful of them link together as short chains, you get a peptide; string far more together, and you get a full protein.

Many peptides act as signaling molecules: their exact sequence determines how they interact with cells, almost like a key shaped for one lock, and a small change can give two peptides completely different functions. That specificity is why peptides remain an active area of drug discovery. Natural peptides already at work in your body help regulate blood sugar, hormone activity, digestion, and immune defense, along with other bodily functions tied to metabolism and cell metabolism generally.

Synthetic Peptides vs. Natural Peptides

Synthetic peptides are built or modified in a lab, sometimes copying a natural signal exactly and sometimes engineered to bind a receptor more precisely. Neither origin tells you much about safety on its own: synthetic versions aren't automatically unsafe, and natural peptides aren't automatically effective.

How Do Peptides Work?

Peptides work by activating, blocking, replacing, or reproducing a specific biological signal, and because each one binds a specific receptor, peptide therapy is often described as targeted therapy, even though the target differs by compound.

Some peptides bind receptors and trigger signal transduction, the chain reaction inside a cell once a receptor fires. Others work upstream: peptides stimulate hormone release, immune signaling, or tissue-repair pathways depending on the compound, and a few replace a hormone the body can't produce on its own. Peptides do not all reduce inflammation, promote tissue repair, cause weight loss, support muscle growth, deliver improved energy, or slow aging; those are separate claims tied to separate compounds. You'll see peptides marketed for numerous benefits online, but the evidence behind each claim depends entirely on the specific peptide and use in question.

Matching Different Peptide Therapies to the Clinical Need

Before getting into how each category works, start from the other direction: what health need are you addressing, and what's the current FDA status for that specific use?

The named status applies only to the particular product and indication; clinicians evaluate specific peptides and indications one by one, and compounded versions aren't FDA-approved, and the FDA's compounding guidance confirms it doesn't review them for safety, effectiveness, or quality first. A health goal is only the starting point; the right treatment also depends on your diagnosis, health history, lab results, and any contraindications, which is why a good candidate for one peptide in a category might be a poor fit for another peptide in the same row.

Metabolic Peptide Therapies for Blood Sugar and Weight

Metabolic peptide therapies influence blood sugar, appetite, and metabolic function, and this category includes some of the most established peptide medications in clinical practice.

• Insulin. A natural peptide hormone your pancreas makes to move glucose from blood into cells. Synthetic insulin products replace or supplement that supply when the body can't make enough, and formulations vary in how fast they act. Insulin is a well-established medical treatment for a diagnosis, not a general wellness peptide.
• GLP-1 peptides (semaglutide, liraglutide, dulaglutide, exenatide). GLP-1 stands for glucagon-like peptide-1, a hormone these medications mimic to stimulate glucose-dependent insulin release, reduce appetite, and slow stomach emptying. Semaglutide was originally developed for type 2 diabetes before its weight-management use was studied and approved separately, and a clinical review of semaglutide confirms its mechanism and efficacy are well documented for that approved use. Specific products, doses, and indications within this class still aren't interchangeable.
• Tirzepatide. A dual incretin receptor agonist that activates both GLP-1 and GIP receptors to affect appetite, food intake, and glycemic regulation. Different tirzepatide brands carry different approved indications. It should never be combined with another tirzepatide product or GLP-1 receptor agonist, since stacking similar mechanisms raises the risk of low blood sugar and GI side effects (nausea, vomiting) rather than adding benefit.

Growth Hormone Signaling Peptides Explained

Growth hormone secretagogues are peptides that stimulate the pituitary gland to release growth hormone, though they don't all bind the same receptor, and claims about muscle mass, fat loss, or body composition need evidence specific to the exact compound.

• Sermorelin. A 29-amino-acid analog of growth hormone-releasing hormone that signals the pituitary to release its own growth hormone rather than containing GH itself. A clinical review of sermorelin found it well-tolerated, with limited data supporting use in children with growth hormone deficiency. Prometheuz offers injectable Sermorelin to eligible adults 25 and older; current compounded Sermorelin, sourced through regulated compounding pharmacies, is not an FDA-approved finished drug, and use for other goals requires individualized evaluation with medical supervision.
• CJC-1295 and ipamorelin. CJC-1295 is another GHRH analog, while ipamorelin activates the ghrelin receptor through a different pathway. Human research on either remains limited, and neither is FDA-approved for anti-aging or muscle-building use. The FDA has flagged limited safety information and immunogenicity concerns, including injection site reactions and allergic reactions, tied to certain compounded peptide products in this class.
• Tesamorelin. A growth hormone-releasing factor analog that the FDA approved specifically to reduce visceral abdominal fat, but only in adults with HIV-associated lipodystrophy confirmed by CT scan. That approval doesn't extend to general weight loss or stubborn fat in people without HIV, and results can't be applied to sermorelin, CJC-1295, or ipamorelin.

Tissue-Repair Research Peptides and What the Evidence Shows

Tissue-repair peptides get promoted for muscle recovery and wound healing, but most supporting evidence comes from lab or animal studies. A proposed mechanism for faster healing in a rat model doesn't establish that a compound speeds healing in a person.

• BPC-157. Promoted for tendon, ligament, muscle, and digestive-tract repair, with most evidence still preclinical. A narrative review of BPC-157 found only a handful of human pilot studies, with rigorous trials still lacking despite the compound's popularity. It is not FDA-approved, and a systematic review in HSS Journal confirms its use is banned in professional sports, so competitive athletes should know it's prohibited under anti-doping rules.
• TB-500. A fragment related to thymosin beta-4, marketed for muscle, tendon, and wound recovery. Human clinical research is insufficient to support those claims, and quality varies widely outside regulated pharmacy channels, so it shouldn't be called clinically proven for recovery regardless of label claims.

Immune-Modulating Peptide Therapy Explained

Thymosin alpha-1 influences T-cell and immune signaling and has a history of treating infections such as hepatitis B and C in the roughly 35 countries where it's approved, but it is not FDA-approved as a general immune booster in the United States. A 2025 meta-analysis found it reduced 28-day sepsis mortality across 11 randomized trials overall, but that benefit didn't hold up in the higher-quality subgroups, so the evidence is promising but unsettled. It should never be framed as preventing every infection, and boosting immune activity isn't always desirable, particularly for people with active cancer, autoimmune disease, or other health conditions where added immune modulation carries its own risk.

Skin-Focused Peptides and How They're Used

Skin-focused peptides come in oral or topical forms, a different category entirely from injectable peptide medications, and evidence depends heavily on the formulation and route.

• Collagen peptides. Usually sold in powder form; digestion breaks them into smaller peptides and amino acids before absorption. A randomized, placebo-controlled trial found oral collagen peptides improved skin hydration over 12 weeks. As Mayo Clinic staff note about supplements generally, products like these aren't required to prove effectiveness before reaching shelves, which is part of why the underlying research, published in outlets from nutrition journals to titles like the European Journal of Clinical Nutrition, it matters more than label claims.
• GHK-Cu. A copper-binding peptide used in topical skin-care products, studied for collagen signaling and skin appearance. Topical evidence can't be applied to an injectable version, since injectable administration raises separate safety questions. It doesn't work through the same pathway as sermorelin or the metabolic peptides above.

Sexual Function Peptide Therapy: What It Actually Treats

Bremelanotide activates melanocortin receptors and carries one narrow FDA-approved indication rather than a broad one. Marketed as Vyleesi, it's approved for hypoactive sexual desire disorder in premenopausal women, not as a universal libido treatment or a substitute for erectile dysfunction medication. That same clinical review found trials showed a significant improvement in desire and less related distress, though the benefit size was described as modest, and its evidence doesn't extend to every sexual-function concern.

Ready to Sort Out Which Peptide Category Fits Your Goals?

A licensed clinician can review your health history against the actual evidence for each peptide category, not just the marketing around it.

Start Your Peptide Therapy Consultation With Prometheuz

Anti-Aging and Healthy-Aging Research Peptides

Healthy-aging peptides get promoted heavily through wellness clinics, but most remain experimental, and a mechanistic finding in a lab doesn't prove a compound slows aging in people.

• MOTS-c and SS-31. MOTS-c is a mitochondrial-derived peptide studied for metabolism and cellular stress; SS-31 is studied for mitochondrial membrane effects. Both are marketed for improved energy, but human evidence for either claim is limited or narrowly condition-specific.
• Epitalon and FOXO4-DRI. Epitalon is promoted for telomere and healthy aging effects, while FOXO4-DRI is studied in connection with senescent cells. Most findings for both remain preclinical; standardized human dosing isn't established, and neither is an FDA-approved anti-aging treatment.

Peptide Injections and Other Delivery Methods

Delivery depends on a peptide's stability, absorption, approved formulation, and target. Digestive enzymes break most peptides into amino acids before they can act, which is why injectable peptides are so common: subcutaneous injection bypasses that breakdown, though route-specific safety and evidence still matter, along with accurate measurement, sterile technique, and correct storage. Injection site reactions can include redness, swelling, or itching and rarer allergic reactions, so clear dosing instructions matter. Some peptides are modified for oral use, collagen typically comes in powder form, skin peptides go on topically, and a few are formulated for nasal use; evidence from one route can't be assumed to apply to another since absorption and dosing shift by formulation.

FDA-Approved, Compounded, and Experimental Peptides Are Not the Same

A peptide's regulatory status determines how much evidence and oversight actually supports it, and that status varies enormously across this category.

• FDA-approved peptide medication: reviewed for a specific product, dose, route, and indication
• Compounded peptide medication: prepared for an individual patient and not FDA-approved
• Dietary peptide supplement: regulated differently from prescription medication
• Experimental peptide: lacks an approved clinical use
• Gray-market peptide: sold outside appropriate clinical and regulatory channels

FDA approval applies only to a peptide's specific approved use, not every claim made about it online, and a pharmacy's involvement in compounding doesn't make a product FDA-approved. "Research use only" products aren't intended for human use and shouldn't be purchased for self-injection. The FDA's list of bulk substances with safety concerns includes BPC-157, citing impurities, difficulty characterizing the active ingredient, and a lack of human safety data. Regulated sourcing and real clinical oversight matter as much as which peptide you're considering.

Weighing the Potential Benefits and Risks of Peptide Therapy

Peptides used for blood sugar don't work like peptides used for hormone release, tissue signaling, skin health, or immune modulation, and the potential benefits and potential risks differ just as much between approved, compounded, and experimental options. A licensed clinician can weigh your medical history and goals against the evidence for your overall health, rather than treating "peptide therapy" as one interchangeable decision.

Frequently Asked Questions

Are peptides safe to use?

It depends on the specific peptide, its regulatory status, and medical supervision. FDA-approved peptide medications used for their approved indication have documented safety profiles, while compounded or research-only peptides carry far less certainty.

How do I know if I'm a good candidate for peptide therapy?

A good candidate is someone whose diagnosis, medical history, and lab results support a specific, evidence-backed use, confirmed by a licensed clinician rather than by a marketed benefit alone.

What do we know about long-term safety?

Long-term safety is well established for FDA-approved peptides tested in large trials, like insulin and GLP-1 medications, but it's largely unknown for compounded and experimental peptides such as BPC-157 or CJC-1295, since human data is still limited.

Is BPC-157 legal for athletes?

BPC-157 is not FDA-approved, and it is prohibited under World Anti-Doping Agency rules, so competitive athletes who test positive can face sanctions regardless of how they obtained it.

Editorial Note: This article draws only on peer-reviewed studies and primary medical sources, including PubMed, NIH, FDA, or professional medical associations, consistent with Prometheuz's LegitScript-certified approach to health content.

References

Chao AM, Tronieri JS, Amaro A, Wadden TA. Semaglutide for the treatment of obesity. Trends Cardiovasc Med. 2023;33(3):159-166. doi:10.1016/j.tcm.2021.12.008. PMID: 34942372. https://pubmed.ncbi.nlm.nih.gov/34942372/

Vasireddi N, Hahamyan H, Salata MJ, Karns M, Calcei JG, Voos JE, Apostolakos JM. Emerging use of BPC-157 in orthopaedic sports medicine: a systematic review. HSS J. 2025;21(4):485-495. doi:10.1177/15563316251355551. PMID: 40756949. https://pubmed.ncbi.nlm.nih.gov/40756949/

Miyanaga M, Uchiyama T, Motoyama A, Ochiai N, Ueda O, Ogo M. Oral supplementation of collagen peptides improves skin hydration by increasing the natural moisturizing factor content in the stratum corneum. Skin Pharmacol Physiol. 2021;34(3):115-127. doi:10.1159/000513988. PMID: 33774639. https://pubmed.ncbi.nlm.nih.gov/33774639/

Mayer D, Lynch SE. Bremelanotide: new drug approved for treating hypoactive sexual desire disorder. Ann Pharmacother. 2020;54(7):684-690. doi:10.1177/1060028019899152. PMID: 31893927. https://pubmed.ncbi.nlm.nih.gov/31893927/

Gu B, Zhou Y, Nie Y, Wang L, Liang L, Liao Z, Wen J, Guan X, Chen M, Wu J, Pei F. Efficacy of thymosin α1 for sepsis: a systematic review and meta-analysis of randomized controlled trials. Front Cell Infect Microbiol. 2025;15:1673959. doi:10.3389/fcimb.2025.1673959. PMID: 40969554. https://pubmed.ncbi.nlm.nih.gov/40969554/

Sandberg K, Albertsson-Wikland K. Sermorelin: a review of its use in the diagnosis and treatment of children with idiopathic growth hormone deficiency. BioDrugs. 2007;21(5):319-328. PMID: 18031173. https://pubmed.ncbi.nlm.nih.gov/18031173/

US Food and Drug Administration. Theratechnologies receives FDA approval for EGRIFTA WR (tesamorelin F8) to treat excess visceral abdominal fat in adults with HIV and lipodystrophy. Updated March 25, 2025. https://www.eatg.org/hiv-news/theratechnologies-receives-fda-approval-for-egrifta-wr-tesamorelin-f8-to-treat-excess-visceral-abdominal-fat-in-adults-with-hiv-and-lipodystrophy/

US Food and Drug Administration. Certain bulk drug substances for use in compounding that may present significant safety risks. https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks

US Food and Drug Administration. Compounding and FDA: questions and answers. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers

Disclaimer

This content is for educational purposes only and does not replace medical advice. Testosterone therapy and hormone-related decisions should be guided by a licensed healthcare provider.